How has Herceptin been studied for the adjuvant treatment of HER2+ breast cancer?
• A: Herceptin has been studied in four large clinical trials of over 10,000 women. Patients participating in the clinical trials received either Herceptin plus chemotherapy or chemotherapy alone. In addition to chemotherapy, some patients in these trials received radiation therapy, and some received hormonal therapy depending on their type of tumor.
